NI200900074A - Tratamiento de los trastornos generalizados del desarrollo - Google Patents
Tratamiento de los trastornos generalizados del desarrolloInfo
- Publication number
- NI200900074A NI200900074A NI200900074A NI200900074A NI200900074A NI 200900074 A NI200900074 A NI 200900074A NI 200900074 A NI200900074 A NI 200900074A NI 200900074 A NI200900074 A NI 200900074A NI 200900074 A NI200900074 A NI 200900074A
- Authority
- NI
- Nicaragua
- Prior art keywords
- disorder
- pdd
- developmental disorders
- treatment
- asperger
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención es un método de tratamiento de Trastornos Generalizados del Desarrollo (PDD's), que incluyen: Trastono Autista, Trastorno de Asperger, Trastorno Desintegrativo Infantil (CDD), Trastorno de Rett, y PDD No Especificado de otra manera (PDD-NOS), que comprende administrar a un sujeto en necesidad del mismo una cantidad terapéuticamente efectiva de uno o más compuestos de carbamato de Fórmula 1 y /o de Fórmula 2, como aquí se define y se muestra mas abajo. La presente invención está dirigida a un método de tratamiento de Trastornos Generalizados del Desarrollo (PDD's), que incluyen: Trastono Autista, Trastorno de Asperger, Trastorno Desintegrativo Infantil (CDD), Trastorno de Rett, y PDD No Especificado de otra manera (PDD-NOS), que incluyen monoterapia y alternativamente, coterapia con al menos un medicamento psiciactivo adicional.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86359506P | 2006-10-31 | 2006-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI200900074A true NI200900074A (es) | 2010-02-01 |
Family
ID=39145417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI200900074A NI200900074A (es) | 2006-10-31 | 2009-04-30 | Tratamiento de los trastornos generalizados del desarrollo |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080103199A1 (es) |
| EP (1) | EP2089011A1 (es) |
| JP (1) | JP2010508354A (es) |
| KR (1) | KR20090080105A (es) |
| CN (1) | CN101568333A (es) |
| AU (1) | AU2007313911A1 (es) |
| BR (1) | BRPI0718323A2 (es) |
| CA (1) | CA2667909A1 (es) |
| CO (1) | CO6180427A2 (es) |
| EA (1) | EA200970435A1 (es) |
| GT (1) | GT200900112A (es) |
| IL (1) | IL198488A0 (es) |
| MX (1) | MX2009004798A (es) |
| NI (1) | NI200900074A (es) |
| NO (1) | NO20092019L (es) |
| WO (1) | WO2008054984A1 (es) |
| ZA (1) | ZA200903772B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10522240B2 (en) | 2006-05-03 | 2019-12-31 | Population Bio, Inc. | Evaluating genetic disorders |
| US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
| WO2010020585A1 (en) * | 2008-08-18 | 2010-02-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serotonin reuptake inhibitors for the treatment of rett syndrome |
| WO2012018387A2 (en) | 2010-08-02 | 2012-02-09 | Population Diagnotics, Inc. | Compositions and methods for discovery of causative mutations in genetic disorders |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| CA2851388C (en) | 2011-10-10 | 2023-11-21 | The Hospital For Sick Children | Methods and compositions for screening and treating developmental disorders |
| DK2773779T3 (da) | 2011-11-04 | 2020-11-23 | Population Bio Inc | Fremgangsmåder og sammensætninger til diagnosticering, prognose og forebyggelse af neurologiske tilstande |
| WO2013120018A1 (en) | 2012-02-09 | 2013-08-15 | Population Diagnostics, Inc. | Methods and compositions for screening and treating developmental disorders |
| SG11201500919PA (en) * | 2012-08-06 | 2015-04-29 | S1 Pharmaceuticals Inc | Treatment regimens |
| DK2895621T3 (da) | 2012-09-14 | 2020-11-30 | Population Bio Inc | Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande |
| CA2922005A1 (en) | 2012-09-27 | 2014-04-03 | Population Diagnostics, Inc. | Methods and compositions for screening and treating developmental disorders |
| US9457003B2 (en) * | 2013-03-12 | 2016-10-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same |
| WO2016036403A1 (en) | 2014-09-05 | 2016-03-10 | Population Diagnostics Inc. | Methods and compositions for inhibiting and treating neurological conditions |
| KR102635938B1 (ko) * | 2016-12-14 | 2024-02-13 | 에스케이바이오팜 주식회사 | 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
| US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| SI3625368T1 (sl) | 2018-08-08 | 2023-04-28 | Pml Screening, Llc | Postopki z genetskim testiranjem za oceno tveganja za razvoj progresivne multifokalne levkoencefalopatije, ki jo povzroča virus John Cunningham |
| JP2022529781A (ja) | 2019-04-17 | 2022-06-24 | コンパス パスファインダー リミテッド | サイロシビンによるうつ病及び他の様々な障害の治療 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL364638A1 (en) * | 2001-02-27 | 2004-12-13 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating bipolar disorder |
| DK1401424T3 (da) * | 2001-02-27 | 2007-02-26 | Ortho Mcneil Pharm Inc | Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser |
| NZ551954A (en) * | 2001-02-27 | 2008-07-31 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating movement disorders |
| RU2300373C2 (ru) * | 2001-02-27 | 2007-06-10 | Орто-Макнейл Фармасьютикал, Инк. | Карбаматы для предотвращения или лечения нейродегенеративных нарушений |
| DE602005020667D1 (de) * | 2004-09-16 | 2010-05-27 | Janssen Pharmaceutica Nv | Verwendung von 2-phenyl-1,2-ethanediol-(di)carbamaten zur behandlung von epileptogenese |
-
2007
- 2007-10-15 US US11/872,177 patent/US20080103199A1/en not_active Abandoned
- 2007-10-15 EA EA200970435A patent/EA200970435A1/ru unknown
- 2007-10-15 EP EP07844287A patent/EP2089011A1/en not_active Withdrawn
- 2007-10-15 AU AU2007313911A patent/AU2007313911A1/en not_active Abandoned
- 2007-10-15 CA CA002667909A patent/CA2667909A1/en not_active Abandoned
- 2007-10-15 WO PCT/US2007/081365 patent/WO2008054984A1/en active Application Filing
- 2007-10-15 JP JP2009535384A patent/JP2010508354A/ja not_active Withdrawn
- 2007-10-15 MX MX2009004798A patent/MX2009004798A/es not_active Application Discontinuation
- 2007-10-15 BR BRPI0718323-2A patent/BRPI0718323A2/pt not_active Application Discontinuation
- 2007-10-15 KR KR1020097011061A patent/KR20090080105A/ko not_active Application Discontinuation
- 2007-10-15 CN CNA2007800482055A patent/CN101568333A/zh active Pending
-
2009
- 2009-04-30 GT GT200900112A patent/GT200900112A/es unknown
- 2009-04-30 IL IL198488A patent/IL198488A0/en unknown
- 2009-04-30 NI NI200900074A patent/NI200900074A/es unknown
- 2009-05-25 NO NO20092019A patent/NO20092019L/no not_active Application Discontinuation
- 2009-05-29 ZA ZA200903772A patent/ZA200903772B/xx unknown
- 2009-06-01 CO CO09056106A patent/CO6180427A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200970435A1 (ru) | 2009-10-30 |
| MX2009004798A (es) | 2009-08-12 |
| NO20092019L (no) | 2009-06-23 |
| JP2010508354A (ja) | 2010-03-18 |
| CA2667909A1 (en) | 2008-05-08 |
| AU2007313911A1 (en) | 2008-05-08 |
| EP2089011A1 (en) | 2009-08-19 |
| BRPI0718323A2 (pt) | 2013-11-26 |
| ZA200903772B (en) | 2010-08-25 |
| WO2008054984A1 (en) | 2008-05-08 |
| KR20090080105A (ko) | 2009-07-23 |
| IL198488A0 (en) | 2010-02-17 |
| US20080103199A1 (en) | 2008-05-01 |
| CO6180427A2 (es) | 2010-07-19 |
| CN101568333A (zh) | 2009-10-28 |
| GT200900112A (es) | 2010-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI200900074A (es) | Tratamiento de los trastornos generalizados del desarrollo | |
| UY29963A1 (es) | Compuestos terapéuticos: piridinas y pirazinas como andamios | |
| PE20110671A1 (es) | Derivados de diazabicicloalcanos como moduladores de la actividad de los receptores nicotinicos de la acetilcolina | |
| EA201200054A1 (ru) | Лечение токотриенолами или экстрактами, богатыми токотриенолами, первазивных расстройств развития | |
| EA200870556A1 (ru) | Комбинированная терапия в лечении эпилепсии и родственных расстройств | |
| PH12014502584A1 (en) | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators | |
| PH12015500817A1 (en) | Methylene linked quinolinyl modulators of ror-gamma-t | |
| EA201171098A1 (ru) | 8-замещенные хинолины и родственные аналоги в качестве модуляторов сиртуина | |
| ECSP077275A (es) | Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos | |
| TW200740773A (en) | Diaminopyrimidines as P2X3 and P2X2/3 modulators | |
| CR10383A (es) | Derivados triazolopirazina. | |
| CL2010001467A1 (es) | Compuestos derivados de fenil-imidazol sustituido con un heteroaromatico biciclico; composicion farmaceutica que los comprende; y su uso como inhibidores de la pde10a para tratar trastornos neurodegenerativos o psiquiatricos como alzheimer, demencia alcoholica, trastorno del aprendizaje, esquizofrenia, adiccion a las drogas. | |
| DK2023918T3 (da) | Cyclosporiner til behandlingen og forebyggelse af okulære lidelser | |
| ECSP099308A (es) | Métodos de tratamiento de la depresión | |
| NI200700316A (es) | Aminopirimidinas como moduladores de la cinasa | |
| CO6612246A2 (es) | Derivados de 2-arilimidazol como inhibidores de enzima pde10a | |
| DOP2011000055A (es) | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoxi-etil)-4-trifluorometoxi-1h-indol-3-il]-metanona como un inhibidor de la triptasa de mastocitos | |
| EA201170976A1 (ru) | Получение и виды терапевтического применения (2s,3r)-n-2-((3-пиридинил)метил)-1-азабицикло[2.2.2]окт-3-ил)-3,5-дифторбензамида | |
| BRPI0809996B8 (pt) | compostos, seus usos para tratar um distúrbio proliferativo, viral, neurodegenerativo, do snc, diabetes, alopecia e um acidente vascular cerebral, e composições farmacêuticas | |
| NZ597866A (en) | Therapeutic lactams | |
| RU2011103475A (ru) | Новая возможность борьбы с гиардиазом | |
| EA201070495A1 (ru) | МОДУЛЯТОРЫ АКТИВНОСТИ γ-СЕКРЕТАЗЫ ИЗ ГРУППЫ ПИПЕРИДИНИЛА И ПИПЕРАЗИНИЛА | |
| ECSP088280A (es) | Compuestos de imidazol para el tratamiento de trastornos neurológicos | |
| AR054220A1 (es) | 5-fenilpirimidinas i sustituidas, composicion farmaceutica y uso del compuesto para la fabricacion de un medicamento | |
| NI201000065A (es) | CARBONO UNIDO A LOS MODULADORES DE LA y-SECRETASA. |